Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Vyne Therapeutics Inc
VYNECurrent price
3.16 USD
+0.01 USD (+0.32%)
Last closed
3.16 USD
Company
www.vynetherapeutics.com
ISIN
US92941V2097
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
39 085 912 USD
Yield for 12 month
+3.78 %
1Y
3Y
5Y
10Y
15Y
VYNE
VYNE Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on developing proprietary and therapeutics for the treatment of immuno-inflammatory conditions. The company's lead product is VYN201, a locally administered pan- bromodomain and extra-terminal (BET) inhibitor soft drug to address diseases involving multiple, diverse inflammatory cell signaling pathways with low systemic exposure. It also develops VYN202, a BD2-selective oral small molecule BET inhibitor for the treatment of immuno-inflammatory indications. The company was formerly known as Menlo Therapeutics Inc. and changed its name to VYNE Therapeutics Inc. in September 2020. VYNE Therapeutics Inc. was founded in 2003 and is based in Bridgewater, New Jersey. Address: 685 Route 202/206 N, Bridgewater, NJ, United States, 08807
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
5.58 USDP/E ratio
1.5407Dividend Yield
–Current Year
+424 000 USD
Last Year
+477 000 USD
Current Quarter
+198 000 USD
Last Quarter
+98 000 USD
Current Year
+424 000 USD
Last Year
+477 000 USD
Current Quarter
+198 000 USD
Last Quarter
+98 000 USD
Key Figures VYNE
1 year
3 years
5 years
10 years
EBITDA
-29 186 000 USD
Operating Margin TTM
PE Ratio
1.5407
Return On Assets TTM
-34.54 %
PEG Ratio
–
Return On Equity TTM
-60.47 %
Wall Street Target Price
5.58 USD
Revenue TTM
486 000 USD
Book Value
5.15 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
46.7 %
Dividend Yield
–
Gross Profit TTM
477 000 USD
Earnings per share
1.72 USD
Diluted Eps TTM
1.72 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics VYNE
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History VYNE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:18
Payout Ratio
–
Last Split Date
13.02.2023
Dividend Date
–
Stock Valuation VYNE
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
1.5407
Forward PE
–
Enterprise Value Revenue
10.0433
Price Sales TTM
80.4237
Enterprise Value EBITDA
1.8403
Price Book MRQ
0.5221
Financials VYNE
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators VYNE
For 52 weeks
1.57 USD
4.48 USD
50 Day MA
2.04 USD
Shares Short Prior Month
58 194
200 Day MA
2.19 USD
Short Ratio
1.23
Shares Short
49 968
Short Percent
0.34 %
BeatStart